Prognostic value of the Kyoto Prognostic Index in higher-risk diffuse large B-cell lymphomas treated by upfront autologous stem cell transplantation in JCOG0908 trial-论文-万方医学网

Prognostic value of the Kyoto Prognostic Index in higher-risk diffuse large B-cell lymphomas treated by upfront autologous stem cell transplantation in JCOG0908 trial

导出原文传递

翻译打印收藏纠错

作者： Kobayashi, Tsutomu ^[1] ; Yamamoto, Kazuhito ^[2] ; Kagami, Yoshitoyo ^[3] ; Machida, Ryunosuke ^[4] ; Miyazaki, Kana ^[5] ; Nakamura, Shigeo ^[6] ; Kuroda, Junya ^[7] ; Maruyama, Dai ^[8] ; Nagai, Hirokazu

作者单位： Grad Sch Med Sci,Kyoto Prefectural Univ Med ^[1] Dept Hematol & Cell Therapy,Aichi Canc Ctr ^[2] Dept Hematol,Toyota Kosei Hosp ^[3] JCOG Data Ctr,Natl Canc Ctr ^[4] Dept Hematol & Oncol,Mie Univ ^[5] Dept Pathol,Nagoya Univ ^[6] Dept Hematol & Oncol,Japanese Fdn Canc Res ^[7] Dept Hematol,Natl Hosp Org ^[8]

关键词 diffuse large B-cell lymphoma International Prognostic Index Kyoto Prognostic Index autologous stem cell transplantation CHEMOTHERAPY PLUS RITUXIMAB INFLAMMATION SURVIVAL CHOP IPI

发布时间 2022-07-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除